HypaHub, Inc.

CANDES AI

Software as a service (SaaS) services and platform as a service (PaaS) services, all of the foregoing featuring computer software for analyzing and monitoring potential cancer signs, symptoms, and drug responses, and making treatment recommendation through artificial intelligence, bioinformatics, and multi-modal data for use by medical professionals, oncologists, and other health systems to assist decision making for patients;

HYPACADD

Infrastructure as a service (IAAS) services, namely, hosting servers for use by others; Infrastructure as a service (IAAS) services, namely, hosting software for medical research, pharmaceutical research, and computer aided drug design for use by others; Compiling data for research purposes in the field of medical science, computer aided drug design, and medical consultancy; Software as a Service (SAAS) services, namely, hosting, managing, developing, and maintaining online applications, software, and web sites, in the field of medical science, computer aided drug design, binding affinity prediction, molecular dynamics, lead search and optimization, molecule modeling, and medical consultancy, mobile information access, and remote data management for wireless delivery of content to handheld computers, laptops and mobile electronic devices; Compiling data for research purposes in the field of medical science, computer aided drug design, and medical consultancy; Computer programming in the medical field relating to medical science and computer aided drug design; Providing medical and scientific research information in the fields of pharmaceuticals and computer aided drug design; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals, computer aided drug design, and genetics;

HYPAHEALTH

Software as a service (SaaS) services and platform as a service (PaaS) services, all of the foregoing featuring computer software for analyzing and monitoring potential cancer signs, symptoms, and drug responses, making treatment recommendation, and discovering drug targets and drugs through artificial intelligence, bioinformatics, and multi-modal data for use by medical professionals, oncologists, scientists and other health systems in the fields of diagnostics, research, healthcare, and pharmaceutical; Pharmaceutical research and development; Drug discovery services; Software as a service (SaaS) services, namely, hosting software for use by others for pharmaceutical research and drug discovery;

HYPAHUB

Downloadable computer software for use in software development;HYPA HUB;Provision of an online marketplace for buyers and sellers of goods and services;Computer programming; software as a service (SaaS) services and platform as a service (PaaS) services, all of the foregoing featuring computer software for developing and managing of software workflow, for the development and collaborative development of software, for data processing and analysis, and for the selling, buying, sharing and exchange of software and data; hosting online web facilities for others for the collaborative development of software; application service provide (ASP), namely, hosting computer software applications of others; hosting the software, websites and other computer applications of others on a virtual private server; computer services, namely, integration of computer software into multiple systems and networks; data migration services; electronic data storage services; computer software consulting services; technical support services, namely, troubleshooting of computer software problems; computer technology support services, namely, help desk services; and computer services, namely, creating an on-line community for users to participate in discussions, get feedback from their peers, form virtual communities, and engage in social networking services in the field of software development;

RESPONSIVE-TREATMENT

Software as a service (SaaS) services and platform as a service (PaaS) services, all of the foregoing featuring computer software for analyzing and monitoring potential cancer signs, symptoms, and drug responses, making treatment recommendation, and discovering drug targets and drugs through artificial intelligence, bioinformatics, and multi-modal data for use by medical professionals, oncologists, scientists and other health systems in the fields of diagnostics, research, healthcare, and pharmaceutical; Pharmaceutical research and development; Drug discovery services; Software as a service (SaaS) services, namely, hosting software for use by others for pharmaceutical research and drug discovery;